COP27 Climate Change Conference-Urgent Action Needed for Africa and the World [0.03%]
气候变迁会议COP27-非洲和世界急需采取行动
Lukoye Atwoli,Gregory E Erhabor,Aiah A Gbakima et al.
Lukoye Atwoli et al.
Errors in Data Set and Effect Sizes for 1 Study Included in Meta-analysis of Delay Discounting as a Transdiagnostic Process in Psychiatric Disorders [0.03%]
数据集中的错误以及包含在精神障碍元分析中的一个研究的影响规模关于延迟折扣作为跨诊断过程的问题
Michael Amlung
Michael Amlung
Meta-Analysis
JAMA psychiatry. 2023 Jan 1;80(1):95. DOI:10.1001/jamapsychiatry.2022.3739 2023
Published Erratum
JAMA psychiatry. 2023 Jan 1;80(1):96. DOI:10.1001/jamapsychiatry.2022.3755 2023
Epidemiology of Untreated Psychoses in 3 Diverse Settings in the Global South: The International Research Program on Psychotic Disorders in Diverse Settings (INTREPID II) [0.03%]
全球南部三个不同环境中的未治疗精神病的流行病学研究：国际跨文化精神病学研究项目(INTREPID II)
Craig Morgan,Alex Cohen,Georgina Miguel Esponda et al.
Craig Morgan et al.
Importance: Less than 10% of research on psychotic disorders has been conducted in settings in the Global South, which refers broadly to the regions of Latin America, Asia, Africa, and Oceania. There is a lack of basic ep...
Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients [0.03%]
药物治疗与住院和死亡之间的关联在瑞典一项对13965名患者的全国性队列中患有安非他明使用障碍的个体中的研究
Milja Hartikainen,Heidi Taipale,Antti Tanskanen et al.
Milja Hartikainen et al.
Importance: There are no medications approved by authorities for the treatment of amphetamine or methamphetamine dependence, and studies investigating the effectiveness of pharmacological treatments in hard outcomes, such...
Randomized Controlled Trial
JAMA psychiatry. 2023 Jan 1;80(1):31-39. DOI:10.1001/jamapsychiatry.2022.3788 2023
How the Cognitive Science of Belief Can Transform the Study of Mental Health [0.03%]
信念的认知科学如何转变精神健康的研究
Eric Mandelbaum,Nicolas Porot
Eric Mandelbaum
Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory Infections [0.03%]
既往神经精神疾病与严重COVID-19感染及其他急性呼吸道感染的风险关联
Tom Alan Ranger,Ash Kieran Clift,Martina Patone et al.
Tom Alan Ranger et al.
Importance: Evidence indicates that preexisting neuropsychiatric conditions confer increased risks of severe outcomes from COVID-19 infection. It is unclear how this increased risk compares with risks associated with othe...
Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US [0.03%]
美国在丁丙诺啡治疗时长方面存在种族和民族差异
Huiru Dong,Erin J Stringfellow,W Alton Russell et al.
Huiru Dong et al.
Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial [0.03%]
基于正念的减压治疗与艾司西肽普兰对焦虑障碍患者的疗效对比——一项随机临床试验
Elizabeth A Hoge,Eric Bui,Mihriye Mete et al.
Elizabeth A Hoge et al.
Importance: Anxiety disorders are common, highly distressing, and impairing conditions. Effective treatments exist, but many patients do not access or respond to them. Mindfulness-based interventions, such as mindfulness-...
Randomized Controlled Trial
JAMA psychiatry. 2023 Jan 1;80(1):13-21. DOI:10.1001/jamapsychiatry.2022.3679 2023
The Intersection of Business Innovation and Scientific Exploration to Address Early Mortality in People With Serious Mental Illness [0.03%]
商业创新和科学探索在解决严重精神疾病患者早期死亡问题上的交集
Karen L Fortuna,Theodore D Cosco,Andrew R Bohm
Karen L Fortuna